Gerard Ber Insider Profile

11 Followers
Gerard Ber, Director at Y-Mabs Therapeutics, holds 21.22K shares in Lantheus (Ticker: LNTH), holds 1.61K shares in Y-Mabs Therapeutics (Ticker: YMAB), holds 0.00 shares in Progenics (Ticker: PGNX).
tipranks
Gerard Ber

Gerard Ber
Y-Mabs Therapeutics (YMAB)
Director

Ranked #79,830 out of 99,172 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-43.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
98.99%
1.01%
A breakdown of Gerard Ber's holdings

Insider Roles

Lantheus
(LNTH)
Director
Y-Mabs Therapeutics
(YMAB)
Director
Roles that Gerard Ber holds in companies

Most Profitable Insider Trade

Stock:
Y-Mabs Therapeutics
(YMAB)
Rating:Informative Sell
Date:Jun 11, 2024 - Today
Return:-20.50%
The most profitable trade made by Gerard Ber

Gerard Ber's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Y-Mabs Therapeutics
Jun 11, 2024
Director
Informative Sell
8.66K
$23.81K
PGNX
Progenics
Jun 23, 2020
Uninformative Sell
$0.00
Lantheus
Aug 14, 2024
Director
Uninformative Sell
1.50M
$2.34M
List of latest transactions for each holding click on a transaction to see Gerard Ber's performance on stock

Gerard Ber insider profile FAQ

What is the percentage of profitable transactions made by Gerard Ber?
The percentage of profitable transactions made by Gerard Ber is 0%.
    What is the average return per transaction made by Gerard Ber?
    The average return per transaction made by Gerard Ber is -43.80%.
      What stocks does Gerard Ber hold?
      Gerard Ber holds: YMAB, PGNX, LNTH stocks.
        What was Gerard Ber’s latest transaction?
        Gerard Ber latest transaction was an Uninformative Sell of $1.50M.
          What was Gerard Ber's most profitable transaction?
          Gerard Ber’s most profitable transaction was an Informative Sell of YMAB stock on June 11, 2024. The return on the trade was -20.50%.
            What is Gerard Ber's role in Y-Mabs Therapeutics?
            Gerard Ber's role in Y-Mabs Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.